CAS: 25521-33-9 - 3-doxyl-17beta-hydroxy-5alpha-androstane
Formula:C23H38NO3
InChI:InChI=1/C23H38NO3/c1-20(2)14-27-23(24(20)26)12-11-21(3)15(13-23)5-6-16-17-7-8-19(25)22(17,4)10-9-18(16)21/h15-19,25H,5-14H2,1-4H3/t15-,16?,17?,18?,19-,21-,22-,23?/m0/s1
- Synonyms:
- 3-DOXYL-17beta-hydroxy-5alpha-androstane,free radical
- [(5S,10S,13S,17S)-17-hydroxy-4',4',10,13-tetramethylhexadecahydro-3'H-spiro[cyclopenta[a]phenanthrene-3,2'-[1,3]oxazolidin]-3'-yl]oxidanyl
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Androstane Spin Label (ASL) REF: TR-A637395CAS: 25521-33-9 | - - - | 245.00 €~1,641.00 € | Mon 23 Dec 24 | |
Androstane Spin Label (ASL)-d3 REF: TR-A637397CAS: 25521-33-9 | - - - | 1,567.00 € | Tue 21 Jan 25 | |
(5α,17β)-17-Hydroxy-4′,4′-dimethylspiro[androstane-3,2′-oxazolidin]-3′-yloxy REF: 3D-ABA52133CAS: 25521-33-9 | Min. 95% | - - - | Discontinued product |
Androstane Spin Label (ASL)
Controlled ProductCAS:25521-33-9
Applications Androstane Spin Label (ASL) is a spin labelled Androstane used to mimic Androstane. References …
Formula:
C23H38NO3
Color and Shape:
Neat
Molecular weight:
376.55
Ref: TR-A637395
10mg | 245.00 € | ||
100mg | 1,641.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Androstane Spin Label (ASL)-d3
Controlled ProductCAS:25521-33-9
Formula:
C23H35D3NO3
Color and Shape:
Neat
Molecular weight:
376.547
Ref: TR-A637397
5mg | 1,567.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
(5α,17β)-17-Hydroxy-4′,4′-dimethylspiro[androstane-3,2′-oxazolidin]-3′-yloxy
CAS:25521-33-9
Please enquire for more information about (5α,17β)-17-Hydroxy-4′,4′-dimethylspiro[androstane-3,2′-oxazolidin]-3′-yloxy including the price, delivery time and more detailed …
Formula:
C23H38NO3
Purity:
Min. 95%
Molecular weight:
376.6 g/mol
Ref: 3D-ABA52133
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |